FT4 immunoassay interference : A case report

##plugins.themes.academic_pro.article.main##

Chaabouni Khansa
Hargafi Khaoula
Elleuch Aida
Messedi Mariem
Turki Mouna
Lahyani Amina
Ayedi Fatma

Abstract

Measurement of thyrotropin and free thyroxin made using immunoassays are usually needed in clinical endocrinology. Here, we report a case of a patient with type 2 diabetes who presented a weight loss. To eliminate hyperthyroidism, thyroid function tests were performed. Free thyroxin (FT4) was decreased using two automated immunoassays TOSOH AIA 1800 and Roche ELECSYS 2010, with a normal thyrotropin value. Thyroid function tests repeated a month later were normal. The patient’s history revealed contact with sheep, which may partly explain the interference. Investigations into the patient’s serum were carried out using both the PEG test and dilution test. Interference factors were probably antibodies. Despite progress in immunoassays, we should be aware of interference occurrence since it can lead to false results, unnecessary investigations and incorrect treatment. Thus, simple tests must be carried out as if interference in immunoassays were suspected. Dilutions and PEG tests are generally performed as first line investigations.

Keywords:

Free thyroxin ; heterophile antibodies ; immunoglobulins ; immunoassay ; interference

##plugins.themes.academic_pro.article.details##

References

  1. Christofides ND, Wilkinson E, Stoddart M, Ray DC, Beckett GJ. Assessment of serum thyroxin binding capacity-dependant biases in free thyroxin assays. Clin Chem 1999;45:520-25
  2. Ismail AAA. A radical approach is needed to eliminate interference from endogenous antibodies in immunoassays. Clin Chem 2005;51:25-6
  3. Cappelli C, Rotondi M, Pirola I, Agosti B, Gandossi E, Valentini U et al. TSH-Lowering effect of metformin in type 2 diabetic patients. Diabetes Care 2009;32:1589-9
  4. Wenzel K W. Pharmacological interference with in vitro tests of thyroid function. Metabolism 1998;30:717-32.
  5. Benoist JF, Biou D, Chevenne D. Dosage des marqueurs biologiques par immunoanalyse. In : Beaudeux J-L, Durand G. Biochimie clinique : marqueurs et perspectives 2ème édition. Paris : Lavoisier SAS, 2011:9- 38.
  6. Convinsky M, Laterza O, Pfeifer J D, Farkas-Szallasi T, Scott M G. An IgM λ antibody to Escherichia coli produces false-positive results in multiple immunometric assays. Clin Chem 2000:46:1157-61.
  7. Levinson S L, Miller J. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta 2002;325:1-15.